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ThymeAbstract Estrogen deﬁciency and insufﬁcient calcium in diet in postmenopause create serious
problems with resultant osteoporosis and fractures. In the present study, forty adult albino rats
weighting 200–220 g were used and divided into ﬁve groups. Group 1, control group included
non-ovariectomized untreated rats. Group 2, ovariectomized)OVX) rats. Group 3, OVX rats daily
received CaCO3 (27 mg/kg b.w.). Group 4, OVX rats daily received a mixture of herbs (sage, rose-
mary and thyme) (30 g/kg b.w.). Group 5, OVX rats daily received both herb mixture and CaCO3.
The results showed signiﬁcant decrease in serum calcium (Ca), inorganic phosphorus (P), total pro-
teins (TP), calcitonin, bone mass density (BMD), reduced glutathione (GSH) and catalase (CAT) in
OVX rats compared to the control group. While a signiﬁcant increase in serum parathyroid hor-
mone (PTH), osteocalcin, alkaline phosphatase (ALP) and acid phosphatase (ACP) were recorded.
Also the recorded data showed increases in femur, tibia and vertebral lipid peroxidation (MAD)
content and the activities of acid phosphatase and alkaline phosphatase in the ovariectomized rats.
On the other hand, when OVX rats were fed on sage, rosemary and thyme supplemented diets or
CaCO3 in a single or in combination, the data recorded a signiﬁcant improvement in all the above
mentioned parameters. Finally, the results of this study indicated that the combination of common
herbs (sage, rosemary and thyme) with calcium carbonate, was more effective in reduction and pre-
vention of osteoporosis in ovariectomized rats. So, it can be concluded that consumption of mixed
herbs supplemented diets might be considered as a functional food for retarding risks of osteoporo-
sis associated with estrogen deﬁciency in OVX states.
ª 2015 The Egyptian German Society for Zoology. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ciency following menopause (postmenopausal osteoporosis)
is by far the most common cause of age-related bone loss. A
sharp decrease in ovarian estrogen production is the predomi-
nant cause of rapid hormone related bone loss during the ﬁrst
decade after menopause (Gruber et al., 1984). Traditional ther-
apies for postmenopausal Osteoporosis have emphasized
agents that inhibit bone resorption such as estrogen
(Centrella and Canalis, 1985), calcitonin (Canalis et al., 1988;
Rudman et al., 1981) and bisphosphonates (Bennet et al.,
1984). Although the most effective method to reduce the rate
of postmenopausal bone loss is estrogen replacement therapy,
it may be accompanied by side effects (Genant et al., 1989) and
thus recommended only for women who are at high risk of
osteoporosis and who have no contraindications. Therefore,
it would be most helpful to study a naturally occurring sub-
stance that minimizes bone loss in postmenopausal women.
Also, recent moves away from hormone replacement therapy
suggested calcium as the simplest and cheapest strategies to
treat and prevent osteoporosis. (Wallace et al., 2004).
Calcium is an essential element in bone mineralization and
formation being the key component of hydroxyapatite and its
use as a monotherapy for osteoporosis are reviewed (Blanch
and Pros, 1999; Flynn, 2003). Optimizing the dietary intake
of calcium is the nutritional goal to prevent osteoporotic frac-
tures in postmenopausal women (Deprez and Fardellone,
2003). Adding three servings of yoghurt to the daily diet of
older women resulted in a signiﬁcant reduction in bone resorp-
tion (Shaker et al., 2005).
There is an increasing interest in phytochemicals as new
sources of natural antioxidant and antimicrobial agents. The
use of synthetic antioxidants in the food industry is severely
restricted as to both application and level (Tawaha et al.,
2007). Currently, there is a strong debate about the safety
aspects of chemical preservatives, since they are considered
responsible for many carcinogenic and teratogenic attributes,
as well as residual toxicity. Plant-derived polyphenols receive
considerable attention because of their potential antioxidant
and antimicrobial properties (Moreira et al., 2005). Phenolic
compounds exhibit a considerable free-radical scavenging
(antioxidant) activity, which is determined by their reactivity
as hydrogen or electron donating agents, the stability of the
resulting antioxidant derived radical, their reactivity with other
antioxidants and, ﬁnally, their metal chelating properties
(Genena et al., 2008).
Salvia ofﬁcinalis L. (sage, common sage, garden sage or
Dalmatian sage) Rosmarinus ofﬁcinalis L. (Rosemary) and
Thymus vulgaris L., (thyme) are medicinal and aromatic plantsof the Lamiaceae (Labiatae) family, native to Mediterranean
countries which today are cultivated all over the world (Gali-
muhtasib et al., 2000). Sage is a popular herb commonly used
as a culinary spice for ﬂavoring and seasoning that has also
been used for centuries in folk medicine for the treatment of
a variety of ailments; also it is found that sage strongly inhibits
bone resorption. Sage is a herbrich ‘‘essential oils are a class of
volatile oils obtained from plants, possessing the odor and
other characteristic properties of the plant’’. Monoterpenes,
the major components of essential oils, belong to the group
of isoprenoids containing 10 C-atoms. Monoterpenes are
widely distributed in the plant kingdom and are present in
some herbs commonly used in human nutrition. As essential
oils and monoterpenes have a pleasant odor and taste when
used at low concentration, they have been extracted since
ancient times also from many plants, both edible and inedible,
and are used today as food additives. As essential oils and
monoterpenes are lipophilic compounds, they readily cross cell
membranes and are therefore absorbed through the skin and
lung there; therefore, there is a long history of use of essential
oils and monoterpenes for many medical applications in oint-
ments, and bath additives to be used in the relief of head and
chest colds as well as muscle pain (Abdallah et al., 2010).
Rosemary (R. ofﬁcinalis L.) and T. vulgaris L., (thyme) are
also spice and medicinal herbs widely used around the world.
The main compounds are a-pinene, bornyl acetate, camphor
and 1,8-cineole (Pintore et al., 2002).
Thyme is employed to season and suppress offensive odors,
such as trimethylamine odor, in foods. The essential oil is well
recognized for its medicinal properties in the treatment of
bronchitis, whooping cough and tooth-ache. It is possible that
the ﬂavonoids present may be important. It was found that the
main components of the essential oil were thymol and car-
vacrol (Porte and Godoy, 2008).
In the light of these ﬁndings, the present study was under-
taken to evaluate weather intake of phytoesterogenic herbs
(sage, rosemary and thyme) could play a positive role in reduc-
ing development of osteoporosis and bone loss associated with
estrogen deﬁciency in OVX rats.
Materials and methods
Experimental animals
Forty adult female albino rats (Rattus rattus) weighing 200–
220 g were used for experimentation. Animals were provided
with a balanced standard diet and water ad-libitum. The ani-
mals were randomly divided into 5 groups each of 8 rats:
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included non-ovariectomized untreated rats.
Group II: Ovariectomized rats group (OVX), included rats
which were ovariectomized on day 1 of the experiment and
sacriﬁced 2 months after ovariectomy.
Group III: OVX rats treated with CaCO3 (27 mg/kg b.w.),
included rats which were ovariectomized on day 1 of the
experiment and received the recommended amount of calcium
for one month (from day 30 to day 60) and then sacriﬁced.
Group IV: Ovariectomized rats given herbs mixture (sage,
rosemary and thyme) in a diet (30 g/kg b.w.) included rats
which were ovariectomized on day 1 of the experiment
and received the doses of mixture herbs for one month
(from day 30 to day 60) and then sacriﬁced.
Group V: Ovariectomized rats treated with
CaCO3 + mixture herbs, included rats which were ovariec-
tomized on day 1 of the experiment and received the recom-
mended amounts of CaCO3 + mixture herbs for one
month (from day 30 to day 60) and then sacriﬁced.
Calcium supplementation: The recommended daily dose of
CaCO3 in women is 1500 mg (Wallace et al., 2004). The recom-
mended dose calculated in rats was 27 mg daily (Paget and
Barnes, 1964) given as calcium carbonate. Twenty seven grams
of calcium carbonate was dissolved in 1000 ml water and each
rat received 1 ml of the suspension daily by an oral tube.
Preparation of the dose of herbs (sage, rosemary and thyme):
The dried leaves of sage, rosemary and thyme were purchased
from Ibn Sina center which is considered a specialized center
formedical herbs inMansoura, Egypt. The herbs were identiﬁed
by Prof Dr. I. Mashaly professor of plant Taxonomy,
Department of Botany, Faculty of Science, Mansoura
University. The dried leaves were ground in a mixer and mixed
with the basal diet as 30 g/kg b.w. (10 g of each type) and were
fed to the rats daily for 1 month (Mu¨hlbauer et al., 2003).
At the end of the experimental period (2 months), animals
were then sacriﬁced, blood samples were collected and the
non-hemolyzed sera were separated for later analysis.
Thereafter, the femur, tibia and vertebrae were cleaned from
surrounding soft tissue, and specimens were removed,
weighed, crushed and homogenized in cool distilled water
and then centrifuged at 3000 r.p.m. the supernatant was then
used for biochemical determinations.
Calcium and phosphorus levels were quantiﬁed using kits
supplied by Bio-diagnostic Co (Cairo, Egypt). Total protein
(TP) content was determined by the method described by
Doumas (1975). Reduced glutathione (GSH) was estimated
according to the method of Prins and Losse (1969). Acid and
alkaline phosphatase activities and the level of lipid peroxida-
tion product of malondialdehyde (MDA) were estimated
according to the method described by Kind and King (1954)
and Ohkawa et al. (1982) respectively. Serum levels of calci-
tonin, parathyroid and osteocalcin were measured using
ELISA Germany kits. Catalase activity was estimated accord-
ing to the method Aebi (1983). BMD was measured according
to Archimedes principle (Kalu, 1991).
Statistical analysis
All results obtained in the present study were evaluated by
One-way ANOVA test and post comparison was carried outwith Tukey-test. The values were expressed as means ± SE
and values of P< 0.05 were considered statistically signiﬁcant
(Snedecor and Cochron, 1989).
Results
As shown in Table 1, the data recorded a signiﬁcant increase in
serum PTH, osteocalcin, acid phosphatase and alkaline phos-
phatase. While there was a signiﬁcant decrease in calcium,
phosphorus, calcitonin and total proteins content in the
ovariectomized rats compared to the untreated controlled rats
group. These changes started to ameliorate when the OVX
were treated with CaCO3 or mixture herbs, but the most ame-
lioration was obtained when the rats received both CaCO3 and
mixture herbs.
Also, the recorded data in Table 2 indicated a signiﬁcant
increase in femur lipid peroxidation, acid phosphatase and
alkaline phosphatase in the OVX rats group. Meanwhile a sig-
niﬁcant decrease in femur bone mass density (BMD), calcium,
phosphorus, total proteins, GSH and catalase, was observed
compared to the controlled rat group. On the other hand, a
treatment with mixture herbs or CaCO3 caused a signiﬁcant
amelioration of the most examined parameters. The best ame-
lioration was observed in the group which received the combi-
nation of CaCO3 and mixture herbs. In OVX rats, the values
of MAD, ALP and ACP levels were signiﬁcantly increased in
the tibial and vertebral tissues compared to the control rat
group. On the other hand, tibial and vertebral BMD, Ca, P,
GSH, CAT and TP levels were signiﬁcantly decreased in the
same OVX group. The treated groups had signiﬁcantly nor-
malized levels in most parameters, but the group which was
treated with the mixture of herbs and CaCO3 had the best
normalization.(Tables 3 and 4).
Discussion
Ovariectomy has shown an increased risk of osteoporosis as
occurs with postmenopausal women. Osteoporosis is a meta-
bolic bone disease characterized by loss of bone mass thus
making the bone more susceptible to fractures (Sakai et al.,
1998). In the present study, ovariectomized rats developed
bone changes similar to those seen in osteoporotic women as
indicated by a decrease in BMD of the femur, tibia and verte-
brae, a ﬁnding that matches with that of Riggs and Melton
(1986), who found that menopause results in elevated bone
turnover, an imbalance between bone formation and bone
resorption and net bone loss, and this is attributable to the ces-
sation of ovarian function and tapering off estrogen secretion
(Heshmati et al., 2002; Elwakf et al., 2014). Recently, consid-
erable attention has been given to the nutritional factors that
can prevent estrogen deﬁciency associated bone loss. In the
present study, feeding diets supplemented with herbs (sage,
rosemary and thyme) exhibited positive effects on BMD. The
obtained results were in agreement with the ﬁndings of
Mu¨hlbauer et al. (2003), who found that bone resorption
was inhibited by the essential oils extracted from these herbs.
The monoterpenes and essential oil extracts act directly on
bone cells via inhibition of the mevalonate pathway and the
prenylation of small G-proteins such as Ras, Rho and Rac
to inhibit bone resorption. (Mu¨hlbauer et al., 2003). Also it
was found that the positive effects of ﬂavonoids on BMD
Table 2 Femur biochemical marker levels in control and different treated rat groups.
Parameters Animal groups
Control Ovx Ovx + CaCO3
27 mg/kg bw
Ovx + Herbs
30 g/kg bw
Ovx + CaCO3 + Herbs
BMD, g/cm2 0.285 ± 0.01 0.159a ± 0.02 0.194ab ± 0.02 0.191ab ± 0.03 0.218ab ± 0.01
Ca, mg/g 150.4 ± 3.7 109.30a ± 4.5 129.31ab ± 9.5 120.39ab ± 3.9 132.82ab ± 8.73
P, mg/g 8.11 ± 0.142 7.33a ± 0.19 8.07b ± 0.15 7.9 7a ± 0.16 8.09b ± 0.19
ACP, K.A.U./g 37.78 ± 0.32 81.93a ± 1.16 61.10ab ± 0.32 65.12ab ± 0.55 55.10ab ± 0.46
ALP, K.A.U./g 25.66 ± 0.39 28.60a ± 0.31 22.64ab ± 0.52 21.62ab ± 0.75 23.62b ± 0.31
MAD, nmol/g 8.13 ± 0.11 11.08a ± 0.12 9.19 ± 0.24 9.26ab ± 0.20 8.78ab ± 0.11
GSH, mg/g 6.59 ± 0.093 5.26a ± 0.100 5.89ab ± 0.075 5.73ab ± 0.130 6.39b ± 0.141
CAT, lmol/min/g 0.633 ± 0.063 0.477a ± 0.015 0.514ab ± 0.006 0.510ab ± 0.016 0.614b ± 0.006
TP, mg/g 7.22 ± 0.06 6.78a ± 0.04 6.94a ± 0.05 6.94a ± 0.09 6.99ab ± 0.08
Data are mean ± SE of 8 rats in each group. Signiﬁcance at P< 0.05. Ovx = ovariectomized group.
a Signiﬁcant difference compared with control group.
b Signiﬁcant difference between Ovx treated groups and Ovx group.
Table 3 Tibial biochemical marker levels in control and treated groups.
Parameters Animal groups
Control Ovx Ovx + CaCO3
27 mg/kg bw
Ovx + Herbs
30 g/kg bw
Ovx + CaCO3 + Herbs
BMD, g/cm2 0.1298 ± 0.009 0.119a ± 0.010 0.1211ab ± 0.008 0.1203ab ± 0.030 0.1235ab ± 0.007
Ca, mg/g 120.3 ± 3.6 98.6a ± 5.2 101.9ab ± 5.9 103.8ab ± 7.3 107.9ab ± 2.1
P, mg/g 76.56 ± 0.14 53.96a ± 0.153 60.04a ± 0.058 59.99ab ± 0.077 66.28b ± 0.01
ACP, K.A.U./g 32.02 ± 0.61 71.42a ± 0.59 47.8ab ± 0.50 53.18ab ± 0.83 43.00ab ± 0.3
ALP, K.A.U./g 27.90 ± 0.42 38.50a ± 0.21 23.72ab ± 0.28 21.90ab ± 0.42 26.18ab ± 0.0
MAD, nmol/g 6.97 ± 0.078 9.15a ± 0.188 8.17ab ± 0.166 8.05ab ± 0.213 7.21b ± 0.20
GSH, mg/g 4.52 ± 0.131 3.39a ± 0.082 3.88ab ± 0.045 3.47ab ± 0.092 4.02ab ± 0.09
CAT, lmol/min/g 0.558 ± 0.007 0.395a ± 0.008 0.470ab ± 0.02 0.487ab ± 0.005 0.516ab ± 0.007
TP, mg/g 5.25 ± 0.09 5.04a ± 0.08 5.23b ± 0.03 5.22b ± 0.04 5.26b ± 0.06
Data are mean ± SE of 8 rats in each group. Signiﬁcance at P< 0.05. Ovx = ovariectomized group.
a Signiﬁcant difference compared with control group.
b Signiﬁcant difference between Ovx treated groups and Ovx group.
Table 1 Serum biochemical marker levels in control and different treated rat groups.
Parameters Animal groups
Control Ovx Ovx + CaCO3
27 mg/kg bw
Ovx + Herbs
30 g/kg bw
Ovx + CaCO3 + Herbs
Ca, mg/dl 8.35 ± 0.05 7.26a ± 0.09 8.11ab ± 0.06 7.96ab ± 0.08 8.03ab ± 0.11
P, mg/dl 3.24 ± 0.49 2.76a ± 0.54 2.8 6ab ± 0.25 2.99ab ± 0.50 3.19ab ± 0.96
PTH, pg/ml 16.86 ± 0.15 29.06a ± 0.20 20.43ab ± 0.10 22.10ab ± 0.13 18.98ab ± 0.08
OCN, ng/ml 3.68 ± 0.08 4.54a ± 0.06 3.67ab ± 0.06 3.82b ± 0.05 3.7 2ab ± 0.06
Calcitonin, pg/ml 4.66 ± 0.087 3.64a ± 0.107 3.94ab ± 0.093 3.54a ± 0.081 4.10b ± 0.107
ACP, K.A.U./dl 28.62 ± 0.34 69.44a ± 0.85 49.16ab ± 0.48 53.70ab ± 0.79 40.80ab ± 0.67
ALP, K.A.U./dl 47.66 ± 0.44 65.00a ± 0.36 55.38ab ± 0.55 52.60ab ± 0.30 58.04ab ± 0.42
TP, g/dl 7.22 ± 0.076 6.78a ± 0.048 6.94a ± 0.057 6.94a ± 0.059 6.99ab ± 0.047
Data are mean ± SE of 8 rats in each group. Signiﬁcance at P< 0.05. Ovx = ovariectomized group.
a Signiﬁcant difference compared with control group.
b Signiﬁcant difference between Ovx treated groups and Ovx group.
84 M.M. Elkomy, F.G. Elsaidand bone formation (Alekel et al., 2000; Setchell and
Lydeking-Olsen, 2003). Flavonoids are a class of phytoestro-
gens; plant-derived chemicals, that when absorbed via the
gut mimic the actions of estrogen (Messina and Messina,
2000) and that have been found to increase bone morpho-
genetic protein 2 (BMP2) gene transcription (Zhou et al.,2003). Sage, thyme and rosemary contain phenolic con-
stituents, which have the potential to bind to the estrogen
receptor (Fetrow and Avila, 2001). These ﬁndings conﬁrm
the observations of other investigators that bone loss in
ovariectomized rats is prevented by estrogen administration,
and that estrogen can also suppress the ovariectomized
Table 4 Vertebral biochemical markers level in control and treated groups.
Parameters Animal groups
Control Ovx Ovx + CaCO3
27 mg/kg bw
Ovx + Herbs
30 g/kg bw
Ovx + CaCO3 + Herbs
BMD, g/cm2 0.134 ± 0.002 0.118a ± 0.003 0.123ab ± 0.008 0.126ab ± 0.007 0.128ab ± 0.008
Ca, mg/g 103.91 ± 3.2 83.98a ± 2.9 92.62ab ± 2.8 89.33ab ± 5.1 96.52ab ± 3.8
P, mg/g 7.83 ± 0.055 7.02a ± 0.08 7.07a ± 0.057 7.00a ± 0.02 7.22ab ± 0.044
ACP, K.A.U./g 30.16 ± 0.32 49.10a ± 0.50 42.16ab ± 0.87 47.88a ± 0.53 36.50ab ± 0.38
ALP, K.A.U./g 27.48 ± 0.35 38.92a ± 0.19 22.70ab ± 0.25 20.42ab ± 0.18 27.48b ± 0.31
MAD, nmol/g 7.08 ± 0.235 10.82a ± 0.174 9.05ab ± 0.207 9.39ab ± 0.155 8.78ab ± 0.165
GSH, mg/g 5.34 ± 0.075 4.42a ± 0.097 5.00ab ± 0.089 4.80ab ± 0.055 4.98ab ± 0.188
CAT, lmol/min/g 0.502 ± 0.009 0.369a ± 0.001 0.511b ± 0.001 0.438ab ± 0.001 0.485b ± 0.002
TP, mg/g 5.03 ± 0.05 4.77a ± 0.08 5.04b ± 0.06 5.01b ± 0.09 5.05b ± 0.04
Data are mean ± SE of 8 rats in each group. Signiﬁcance at P< 0.05. Ovx = ovariectomized group.
a Signiﬁcant difference compared with control group.
b Signiﬁcant difference between Ovx treated groups and Ovx group.
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(Kalu, 1984). Also, the present work indicated that the levels
of bone Ca and P in ovariectomized rats were signiﬁcantly
lower than the control group. These results are in agreement
with Boulbaroud et al. (2008) and Hassan et al. (2013), who
recorded that the levels of serum Ca and P were decreased in
the ovariectomized rats. The obtained results suggested that
ovarian hormone deﬁciency following ovariectomy, is marked
by reduced intestinal calcium absorption and may contribute
to the accompanying bone loss. In addition, the level of
Calcitonin recorded a signiﬁcant decrease in ovariectomized
rats .These results are in agreement with Zaidi et al., 2002,
and may be attributed to the concentration of calcium level
which is considered the principal stimulus for the secretion
of calcitonin by C-cells. When blood calcium is lowered, the
stimulus for calcitonin secretion is diminished. Also the actions
of PTH and calcitonin are antagonistic on bone resorption.
Further, evidence of osteoporosis resulting from ovariectomy
was indicated by the present elevation of PTH level. The ele-
vated level of PTH causes additional loss of BMD in estrogen
deﬁcient animals beyond the rapid bone loss associated with
ovariectomy. Decreased estrogen level in females increased
the sensitivity of bones to the action of PTH, leading to bone
resorption with lower BMD (Krivosı´kov et al., 2010).
Moreover, ovariectomy causes hyperparathyroidism which
may cause calcium change associated with a compensatory rise
in PTH resulting in calcium release from the skeleton thus
causing bone loss (Guillemant et al., 1999). Treatment with
sage, rosemary and thyme, restored the decreased levels of
serum Ca and P to normal values. Phytoestrogenic compounds
in sage, rosemary and thyme have structural similarities to
estrogen conformation and binding capabilities to estrogen
receptors, which may therefore promote calcium absorption
through an estrogen receptor pathway within intestinal cells
(Arjmandi et al., 2002).
The present study revealed that the raised bone ALP and
ACP activity occurring with ovariectomy could contribute to
high bone turnover rate, being characterized by an increase
in both bone resorption and formation, but bone resorption
excesses formation, leading to bone loss (Elwakf et al., 2014)
thus, indicating an increase in the osteoblastic and osteoclastic
activity, respectively, resulting in an overall net loss of bone
with an increase in the excretion of urinary hydroxyproline,as an index of bone turnover (Wu et al., 2008). The positive
role of medical herbs supplemented diets was also achieved
by the observed improvement of bone metabolic markers
ALP and ACP (Chiechi et al., 2002). Phytoestrogenic herbs
exhibited comparable effects regarding all tested parameters,
indicating almost similar ability of herbs to protect against
bone loss (Boulbaroud et al., 2008).
Phytoestrogens are plant derived polyphenolic compounds,
which are widely used for treatment and protection against
various health problems, including bone diseases (Wilkinson
et al., 2002; Hassan et al., 2013). Phytoestrogens are thought
to protect from bone loss mainly through estrogen dependent
mechanisms as phytoestrogens seemed to directly increase
estrogen levels, as seen in the present study and in other inves-
tigations (Rice and Whitehead, 2008). Phytoestrogens associ-
ated estrogen raise may be related to their structural
similarity to estrogens at the molecular level which may help
to exert estrogen-like activities. It is well documented that
estrogen has high afﬁnity toward estrogen receptor ERa and
ERb on osteoblasts (Beral et al., 2002) and activation of ER
complex is vital in maintaining bone remodeling processes
(Manolagas et al., 2002). Because phytoestrogens have a stable
structure and low molecular weight, they can pass through cell
membranes and interact with estrogen receptors (ER) which
allow them to act through the same intracellular pathways of
estrogens (Toran-Allerand et al., 2002).
Serum osteocalcin (OCN) level is frequently used as the
bone formation marker to monitor drug actions (Kyoko
et al., 2002a,b; Shirwaikar et al., 2003). OCN, an extra cellular
calcium binding protein is expressed by mature osteoblasts in
association with organic matrix mineralization (Patterson-
Buckendahl et al., 1995). Serum osteocalcin levels are most
likely to either reﬂect newly synthesized protein, as well as that
released from bone matrix during resorption (Ducy et al.,
1996; Nian et al., 2006). The present investigation showed that
ovariectomized rats exhibited high levels of osteocalcin .These
results coincided with those of Abdallah et al. (2010), who
showed that ovariectomy induced a rise in serum osteocalcin
level as a result of compensation of increased bone turnover.
In addition, osteocalcin was found to be lowered after sage,
rosemary and thyme administration to rats. This suggests that
they were able to suppress the increased bone turnover due to
estrogen deﬁciency (Wu, 2007). The present results
86 M.M. Elkomy, F.G. Elsaiddemonstrated that total proteins were signiﬁcantly decreased
in ovariectomized rats. The decreased level of total protein is
concomitant with that observed with Hassan et al. (2013),
and this decrease may be attributed to the increase in protein
catabolism. Estrogen plays an important role in regulating
bone metabolism and its deﬁciency was found to cause nega-
tive bone remodeling balance that augments bone loss and
increases incidence of osteopenia. A number of mechanisms
may contribute to this effect; however increased oxidative
stress has a central role (Watkins et al., 2005). This suggestion
was further conﬁrmed in the present study through the ﬁnding
of increased levels of malondialdehyde (MDA) in the bone of
OVX rats, thus, indicating high level of free radicals generation
and oxidative stress due to estrogen deﬁciency.
Oxidative stress represents an imbalance between produc-
tion of reactive oxygen species (ROS) and the ability of the
biological system to readily detoxify these reactive intermedi-
ates or to repair the resulting damage. Disturbances in the nor-
mal redox state of tissues can cause toxic effects through the
production of peroxides that damage cell components, includ-
ing proteins, lipids, and DNA (Janssen-Heininger et al., 2008).
Previous studies supported enhanced oxidative stress in female
rats after ovariectomy and further proposed that ovarian sex
hormones protect tissues against oxidative stress and decrease
the oxidative cell damage (Hassan and Abdel-Wahhab, 2012).
There is evidence that estrogen deﬁciency instates of
ovariectomy activates ROS, such as H2O2 for induction of
bone loss through increased osteoclastic activity (Riggs et al.,
2003). Furthermore, H2O2 not only augments osteoclastic
activity, but also is essential for osteoclastic differentiation
(Steinbeck et al., 1994). The current ﬁndings of increased
H2O2, MDA in the femur, tibia and vertebrae of OVX rats
may indicate that estrogen deﬁciency stimulates ROS that acti-
vates osteoclasts resulting in oxidative damage of bone. In this
regard, it was explained that cells maintain their integrity
against damaging oxygen free radical with the help of the
antioxidant system including GSH-Px, SOD, CAT and GSH
(Clark, 2002). Therefore, the decrease in bone CAT and
GSH reported here, supported those ﬁndings and indicated
the enhancement of oxidative stress as a result of bone tissue
damage.
Phytoestrogens are polyphenolic compounds featuring with
1–3 hydroxyl (–OH) groups that resemble the naturally occur-
ring hydroxyl group on the phenol ring of estrogen. These OH
groups attach free radicals through hydrogen electron denota-
tion (Clark, 2002) resulting in stable antioxidant state.
Phytoestrogens may play an antioxidant role not only by scav-
enging reactive oxygen species, but also via stimulating activity
of the antioxidant enzymes SOD, GSH-Px and CAT. (Munoz-
Castaneda et al., 2005). The natural antioxidant, rosemary has
been widely accepted as one of the spices with the highest
antioxidant activity (Peng et al., 2005). Many compounds have
been isolated from rosemary, including ﬂavones, diterpenes,
steroids, and triterpenes. The antioxidant activity of rosemary
extracts has been primarily related to two phenolic diterpenes:
Carnosic acid and carnosol (Frankel et al., 1996).
In addition, ovarian hormone deﬁciency in women and ani-
mals, including rats, results in a drastic increase in the rate of
bone loss. These rapid rates of bone loss partly are due to a rise
in oxygen derived free radical formation (Garrett et al., 1990
and Xu et al., 1995) Therefore, the phenolic compounds insage, rosemary and thyme may function as free radical scav-
engers, which are likely to suppress the rate of bone loss.
In conclusion, the present data indicated that feeding sage,
rosemary and thyme were able to modulate bon loss in OVX
rats, as represented by the elevation of bone minerals (Ca, P)
and bone mineral density (BMD). This may occur through
similar intracellular pathways, involving the suppression of
oxidative stress and enhancement of antioxidant defense mech-
anism. Thus, sage, rosemary and thyme can be used as a nat-
ural approach to help in preventing bone loss associate with
states of estrogen deﬁciency.
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